Marinus Pharmaceuticals Inc.

(MRNS) Trade

By |

Profile

Marinus Pharmaceuticals Inc is a clinical stage biopharmaceutical company. It is focused on developing and commercializing innovative therapeutics to treat epilepsy and neuropsychiatric disorders. Marinus manages the business in one segment, which is the identification and development of neuropsychiatric therapeutics. The Company is developing ganaxolone for multiple epilepsy and other neuropsychiatric indications, including adjunctive, or add-on, therapy for the treatment of drug-resistant focal onset seizures; status epilepticus; Fragile X Syndrome, and PCDH19 pediatric epilepsy.

Contact Information

Website: www.marinuspharma.com
Email: sdamouni@marinuspharma.com
Main Phone: +1 484 801-4670
Address: 5 Radnor Corporate Center, 100 Matsonford Road
Address 2: Suite 500
State: PA
City / Town: Radnor
Country: US
Postal Code: 19087

Issuer Information

Exchange: NSD
CEO: Scott Braunstein
Employees: 66
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

Profile

Marinus Pharmaceuticals Inc is a clinical stage biopharmaceutical company. It is focused on developing and commercializing innovative therapeutics to treat epilepsy and neuropsychiatric disorders. Marinus manages the business in one segment, which is the identification and development of neuropsychiatric therapeutics. The Company is developing ganaxolone for multiple epilepsy and other neuropsychiatric indications, including adjunctive, or add-on, therapy for the treatment of drug-resistant focal onset seizures; status epilepticus; Fragile X Syndrome, and PCDH19 pediatric epilepsy.

Contact Information

Website: www.marinuspharma.com
Email: sdamouni@marinuspharma.com
Main Phone: +1 484 801-4670
Address: 5 Radnor Corporate Center, 100 Matsonford Road
Address 2: Suite 500
State: PA
City / Town: Radnor
Country: US
Postal Code: 19087

Issuer Information

Exchange: NSD
CEO: Scott Braunstein
Employees: 66
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

$ 12.60 $ -0.13 (-1.02%)
Last Price 12.60 Change $ -0.13 Change % -1.02 Tick N/A
Bid 12.10 Bid Size 700.00 Ask 13.30 Ask Size 200.00
Open 12.76 High 13.10 Low 12.53 Prev Close 12.73
Last Trade Volume 323,269 52 Wk Hi 17.14 52 Wk Low 4.16
Market Cap 448.5 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 35,596,390.00 EPS (TTM) -3.44 PE Ratio -3.70 Exchange NSD
  Last 3 Mo Last 12 Mo
Number of Insider Trades 0 5
Number of Buys 0 2
Number of Sells 0 3
Net Activity 0 -9566
Last 10 Buys Shares
Anand Mehra 1,000
Anand Mehra 1,000
Anand Mehra 1,000
Last 10 Sell Shares
Christopher M. Cashman 1,000
Anand Mehra 1,000
Anand Mehra 1,000
Anand Mehra 1,000
Gail M. Farfel 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 20 18 18 20
Low Target Price Estimate 13 13 13 13
Mean Target Price Estimate 16.5 15.33 15.33 16.5
Standard Deviation 3.11 2.52 2.52 3.11
Date of Most Recent Estimate 06/06/18 05/24/18 05/24/18 06/06/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 3 1 1 1
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 1